CSIMarket
 


United Therapeutics Corporation  (UTHR)
Other Ticker:  
 


United Therapeutics's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is United Therapeutics's ROI in the fourth quarter of 2023?
United Therapeutics Corporation achieved a return on average invested assets (ROI) of 15.77 % in its fourth quarter of 2023, which is below United Therapeutics's average return on investment, which stands at 19%.

Despite the deterioration in its net income, company has improved ROI compared to the third quarter of 2023.

Within the Healthcare sector 19 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2023 quarter, so far to 194, from total ROI ranking in the third quarter of 2023 at 505.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change 11.6 % 14.89 % 21.09 % 18.83 % -
Y / Y Net Income Change 64.35 % 11.83 % 123.45 % 0.42 % 17.74 %
Investment (TTM) in Millions 6,363 6,280 6,311 6,021 5,701
Return On Investment (TTM) 15.77 % 14.8 % 14.83 % 13.01 % 13.57 %
UTHR's Overall Ranking # 194 # 505 # 519 # 634 # 361
Seq. Investment Change 1.32 % -0.5 % 4.81 % 5.61 % 4.31 %
Seq. Net Income Change -18.87 % 3.24 % 7.6 % 82.36 % -44.8 %
Net Income (TTM) in Millions 985 900 872 728 727




Return On Investment UTHR's Ranking
Within: No.
Industry # 11
Sector # 20
Overall # 194

Return On Investment Statistics
High Average Low
57.02 %
19 %
-4.84 %
(June 30. 2016)   (Mar 31 2019)







Financial Statements
United Therapeutics's IV. Quarter Investments $ 6,363 Millions UTHR's Balance sheet
United Therapeutics's IV. Quarter Income $ 217 Millions Quarterly UTHR's Income Statement
UTHR's Income by Division See UTHR's Income by Division


UTHR Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 6,363 5,701 4,864 4,292 3,450
Y / Y Investment Growth 11.6 % 17.22 % 13.33 % 24.38 % 15.6 %
Net Income in Millions 985 727 476 515 -105
Y / Y Net Income Growth 35.4 % 52.86 % -7.58 % - -
Annual Return On Investment 15.48 % 12.76 % 9.78 % 12 % -3.03 %


Annual Roi Comment
In the fiscal year 2023 ROI improved to 15.48 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
UTHR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for UTHR's Competitors
Roi for United Therapeutics's Suppliers
Return On Investment for UTHR's Customers

Other Ratios
UTHR's Roa UTHR's Inventory Turnover Ratio UTHR's Growth Rates UTHR's Dividend Statistics
UTHR's Profitability Ratios UTHR's Asset Turnover Ratio UTHR's Dividend Growth
UTHR's Roe UTHR's Valuation Ratios UTHR's Financial Strength Ratios UTHR's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Idexx Laboratories Inc  40.73 %
Star Equity Holdings Inc   40.67 %
Mimedx Group Inc   38.97 %
Medpace Holdings Inc   37.64 %
Elite Pharmaceuticals Inc   36.55 %
Mettler toledo International Inc   34.44 %
National Research Corporation  34.07 %
Alpha Tau Medical Ltd   31.12 %
Semler Scientific Inc   30.60 %
Virios Therapeutics Inc   28.59 %
Johnson and Johnson  26.63 %
Earth Science Tech Inc   26.10 %
Lantheus Holdings Inc   25.80 %
Inmode Ltd   25.09 %
Corcept Therapeutics Inc  21.53 %
Escalon Medical Corp   20.64 %
Vertex Pharmaceuticals Inc  20.61 %
Chemed Corporation  20.26 %
Novartis Ag  20.19 %
Harmony Biosciences Holdings inc   19.75 %
Catalyst Pharmaceuticals Inc   19.15 %
Zoetis Inc   18.93 %
West Pharmaceutical Services Inc   18.65 %
Protalix Biotherapeutics inc   18.12 %
Edwards Lifesciences Corporation  17.49 %
Exelixis Inc   17.29 %
Halozyme Therapeutics Inc   16.81 %
Astrazeneca Plc  16.41 %
United Therapeutics Corporation  15.77 %
Eli Lilly And Company  15.18 %


Date modified: 2024-02-21T20:48:31+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com